The spikes in my eyes
Release time:
2020-08-14
The peak
■ Jiang Xiaomeng
in my eyes will be the 11th anniversary of the peak start-up 60# and the 38 year of my work in the peak. From a young and ignorant teenager to now, my temples have begun to turn white. I have witnessed the nearly 2/3 course of the peak, including glory and depression, but more hope and longing.
Fortune magazine has reported that the average life expectancy of small and medium-sized enterprises in the United States is less than 7 years, while that of large enterprises is less than 40 years. The average life span of China's small and medium-sized enterprises is 2.5 years, and the average life span of group enterprises is 7 to 8 years. Among the many enterprises in our country, very few have the same peak life as us.
The peak with history
The development of the peak has experienced many great turning points worthy of memory and commemoration, such as setting up cement factory, cross-industry acquisition, merger, diversified operation, integration of pharmaceutical industry... Fortunately, I am a witness to these great events, even a witness.
When I entered the factory, in 1980 , Jinhua Cement Factory was still in the stage of coexistence of ordinary vertical kilns and mechanical vertical kilns. At that time, in the firing workshop, most of the feeding and unloading in the production process depended on manual work. When commuting in winter, you can often see the "brilliant" image of workers wearing hoods, working cotton-padded jackets, and rice basins under their armpits. Because the buttons of the cotton-padded jacket are easy to fall off, some employees still root straw ropes in their waists. The working conditions at that time could not be compared with those now. The dust was flying when adding and unloading materials. At the end of the day, everyone became the same appearance-because they were wearing masks, there were two black shadows on the bridge of the nose, and their bodies were covered in gray. Some people had too much dust on their faces and their eyebrows looked white.
Due to the lack of economy at that time, cement was regarded as a "tight commodity". The roads outside the factory area were full of cars buying cement, large trucks and small tractors, with long lines and even overnight queues. Sometimes it took two or three days for their turn. One winter when it snowed heavily and blocked the road, vehicles transporting limestone could not get in, and production was about to stop. At that time, I was still working in the raw material workshop. The factory organized employees to sweep snow and sweep all the way to the Kowloon mine along the Shuanglong Highway.
Although the working environment is so difficult, we have a sense of superiority regardless of cadres or employees, because we are workers!
With the progress of science and technology and the development of enterprises, 20th century 80# In the mid-1950s, Jianfeng established two branch factories and three branch factories successively through cooperation with township enterprises. Later, he established a building materials group and built the first batch of rotary kiln production lines in Zhejiang Province, which was later Jinma Factory. After entering 21nd century, we went out of the basin and built factories in Fuyang across regions. Until now, Jianfeng Cement has taken root in many provinces and cities across the country.
90 s of the last century, was the first step in the development of Jianfeng across industries. As the first general manager of a cable company, I started from scratch to supplement basic cable courses, engaged in construction, production, and market with my colleagues, and sold peak cables to most provinces and cities across the country. In 1996 , Jianfeng cross-regional merger of Linhai Pharmaceutical Factory, reorganization of the establishment of Zhejiang Jianfeng Haizhou Pharmaceutical Co., Ltd., to build a raw material drug production base. This requires considerable boldness when talents, technology and other factors were not available at that time. Although this first step was not satisfactory and later withdrew, this merger accumulated experience and trained a team for the development of Jianfeng in the pharmaceutical field. Only then did it acquire Jinhua Biochemical Pharmaceutical Factory, set up Jianfeng Pharmaceutical Company, and took a stake in Tianshili Group, finally forming a development pattern of cement and pharmaceutical dual main businesses.
tons to a cross-industry and cross-regional comprehensive enterprise group, and finally form a development strategy of "cooperative innovation to strengthen the main business; standardize science and seek development". It has created the current achievements of the peak.
3800 kilometers; "Jianfeng" brand cement is a famous brand product in Zhejiang, Hubei, Yunnan and other provinces and cities; all environmental protection indicators have reached or led the international and domestic standards, and the production process and technical indicators are among the best in the country. It is in cost control, quality control, The profit indicators of tons of cement are all ahead of the same industry, and this year has achieved the best results in history. The
76 document numbers, exceeding the sales of 10 .1 billion yuan. It has recruited talents from all walks of life in the country and trained a large number of teams who are loyal to the peak, love their posts and work hard, bear hardships and stand hard work, have combat effectiveness and professional qualities. In Tianjin, we have Tianjin Jianfeng Natural Products Company, a leading enterprise of plant extracts in China; in Jinhua, we have recently built a large-scale Jinxi pharmaceutical base and set up a Sino-German joint venture Jinder Baby Drug Company; this year, we have also participated in Beijing Huibaoyuan Biotechnology Company ...... While the pharmaceutical territory continues to expand, the health industry sector centered on Jianfeng Health Technology Company is also showing its embryonic form.
DPT under development is also the first major national innovation project in Jinhua's history. Many products have also been listed as the national high-tech industrialization demonstration project, the national key new product plan project and the national torch plan project. Cefmenoxime hydrochloride for injection has also created a history of over 100 million yuan in sales of single products; peak Pharmaceutical has also been rated as a national high-tech enterprise for more than 10 years.
Now, the peak is about to enter the 107 60
Finally, I would also like to thank the old peak people of all ages for their efforts in the cause of peak. We will not forget those old leaders, old employees, and old colleagues who have worked hard for the peak cause. Their conscientious and selfless dedication is the source and driving force of the development of the enterprise, and it also inspires generations of peak people to move forward courageously on the road of a century-old peak.
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31